Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04639024
Title ADCT-301 in Patients With R/R AML, MDS, or MDS/MPN
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gwynn Long, M.D.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.